Searchable abstracts of presentations at key conferences in endocrinology

ea0059ep71 | Neuroendocrinology and pituitary | SFEBES2018

Internal carotid artery haemorrhage in a patient with a radiotherapy treated pituitary macroadenoma with sphenoid extension and osteonecrosis

Butterly EW , Boyle R , Drummond R , Carty DM , Boyle JG , Currie G , Hughes KA

Pituitary macroadenomas often extend to the suprasellar region, however rarely they can extend inferiorly and include erosion into the sphenoid bone, presenting unique challenges. We present a 74-year-old female who received pituitary radiotherapy in 1995 for a pituitary macroadenoma with sphenoid extension. She initially presented in 1994 with secondary amenorrhoea and hyperprolactinaemia (30,000 mu/l). She could not tolerate MRI and subsequent CT showed a pituitary macroaden...

ea0019p272 | Pituitary | SFEBES2009

A single early morning serum cortisol in the early post operative period following transphenoidal surgery for pituitary tumours accurately predicts hypothalamo–pituitary–adrenal function

Jayasena CN , Gadhvi KA , Gohel B , Martin NM , Mendoza N , Meeran K , Dhillo WS

Background: Secondary adrenal insufficiency is a common complication of transsphenoidal hypophysectomy (TSS) for pituitary adenoma. It is therefore imperative to rapidly and accurately identify patients requiring glucocorticoid replacement, thus minimising risks of adrenal insufficiency or unnecessary glucocorticoid exposure. The gold-standard test of HPA axis reserve, the insulin tolerance test (ITT), cannot be performed safely until after post-operative recovery. Nine am cor...

ea0011p917 | Thyroid | ECE2006

Thyroid cancer management: are guidelines being met?

Chahal HS , Velmurugan S , Mellish SA , Lewis R , Metcalfe KA , Ahlquist JA

Thyroid cancer is the commonest malignancy seen in endocrine practice. Audits of clinical practice have revealed significant variations in management, and the British Thyroid Association have published guidelines (2002) to address this. The aim of our study was to assess the care-stage at which practice falls short of agreed standards. We performed retrospective case note review of 83 patients (72 female) followed in a specialist thyroid cancer clinic over 5 years. Histology d...

ea0056oc9.2 | Thyroid from basics to clinics | ECE2018

Anti-tumoral effects of metformin on metastatic bone lesions of thyroid cancer

Cho Sun Wook , Shin Hyo Sik , Sun Hyun Jin , Park Young Joo , Yi Ka Hee

Background: Metformin plays anti-tumoral roles in human cancers including breast and thyroid. However, its effects on metastatic lesions are undetermined. We studied the effects of metformin on bone metastasis of thyroid cancer.Method: Luciferase-tagged anaplastic FRO and follicular FTC 133 thyroid cancer cells were used. In vivo effects of metformin were evaluated in both ectopic tumor model and bone metastasis model generated by intratibial injection.<...

ea0093p5 | Guided Poster Tour 1: Adrenal and Neuroendocrine tumors | EYES2023

An overview of adrenal vein sampling for primary aldosteronism in Croatia (2016–2023)

Lekić Ivan , Tomšić Karin Zibar , Alduk Ana Marija , Kaštelan Darko

Background: Although adrenal vein sampling (AVS) is a technically demanding procedure, it is still considered the gold standard for subtyping primary aldosteronism (PA). The aim of the study was to analyze the success rate of AVS in patients with PA.Methods: In all patients AVS was performed sequentially during continuous stimulation with adrenocorticotrophic hormone by one interventional radiologist. Adrenal vein cannulation was considered successful if...

ea0099ep234 | Adrenal and Cardiovascular Endocrinology | ECE2024

The effect of adrenalectomy on metabolic parameters in patients with primary aldosteronism

Zibar Tomšić Karin , Đukić Mirjana , Solak Mirsala , Kaštelan Darko

Background: A few studies have shown that aldosterone has negative impact on metabolic parameters.Objectives: The aim of the study was to evaluate metabolic parameters in patients with primary aldosteronism (PA) before and one year after adrenalectomy.Methods: In this retrospective study, we examined 51 patients (median age 50 years, IQR 43–55; 55% male) who underwent adrenalectomy for PA between 2016 and 2022. Patients with d...

ea0081p710 | Reproductive and Developmental Endocrinology | ECE2022

Age- and body mass index-adjusted association between insulin sensitivity and risk factors for cardiovascular disease in polycystic ovary syndrome

Kałużna Małgorzata , Krauze Tomasz , Kompf Pola , Ziemnicka Katarzyna , Andrzej Wykretowicz , Ruchala Marek , Guzik Przemyslaw

Introduction: Impaired insulin sensitivity accompanies polycystic ovary syndrome (PCOS). Women with PCOS are usually at risk of premature cardiovascular disease, which increases with age and body weight. We studied the link between insulin sensitivity measured by the Matsuda Insulin Sensitivity Index (MISI) adjusted to body mass index (BMI) and age in otherwise healthy PCOS women.Methods: 250 adult women with PCOS of reproductive age (18-43 years old) un...

ea0049ep1074 | Pituitary - Clinical | ECE2017

Body composition and bone mineral density in male patients with isolated hypogonadotropic hypogonadism

Kałużna Małgorzata , Człapka-Matyasik Magdalena , Przeorska Dorota , Ziemnicka Katarzyna , Ruchała Marek

Isolated hypogonadotropic hypogonadism (IHH) is known to decrease bone mineral density due to lack of pubertal surge of gonadotropins and deficiency of sex steroid hormone. Gonadal steroid hormones imbalance affects body composition. Nineteen Caucasian men, 22–48 year old (mean±S.D. 33±7.65) diagnosed with IHH (8 normosmic, 11 anosmic or hyposmic) were enrolled into the study. 14 patients were on hormone replacement therapy (HRT), 5 patients were ...

ea0073aep129 | Calcium and Bone | ECE2021

CDC73 associated primary hyperparathyroidism and essential tremor

Eliška Svobodová , Rehorkova Pavla , Vcelak Josef , Moravcova Jitka , Havlinova Barbora , Gabalec Filip , Cap Jan

ObjectivePrimary hyperparathyroidism (PHPT) is a common endocrine disorder affecting 2% of the population aged 55 years or older. Primary hyperparathyroidism is due to parathyroid adenoma in about 85% of cases, parathyroid hyperplasia in about 15% of cases, and parathyroid carcinoma in less than 1% of cases. Familial parathyroid disorders are responsible for 10% of the PHPT cases and include among other disorders caused by parafibromin malfunction. Paraf...

ea0093p8 | Guided Poster Tour 1: Adrenal and Neuroendocrine tumors | EYES2023

Remission rate of primary aldosteronism after unilateral adrenalectomy

Đukić Mirjana , Tomšić Karin Zibar , Knežević Nikola , Kaštelan Darko

Background: The existing consensus for patients with primary aldosteronism (PA) after unilateral adrenalectomy recommends annual follow-up to rule out persistence or recurrence of the disease.Objectives: The aim of the study was to assess the remission rate in patients with PA ≥1 year after adrenalectomy.Methods: Of the 41 patients who underwent adrenalectomy for PA between 2016 and 2021, 24 had available follow-up data and w...